Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

Saved in:

Bibliographic Details
Published in:	Blood Cancer J
Main Authors:	Shea, Lauren K., Honjo, Kazuhito, Redden, David T., Tabengwa, Edlue, Li, Ran, Li, Fu-Jun, Shakhmatov, Mikhail, Chiorazzi, Nicholas, Davis, Randall S.
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group UK 2019
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6520396/ https://ncbi.nlm.nih.gov/pubmed/31092813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0207-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items